The present invention relates to systems and methods for ultrasound imaging and, more particularly, to a system and method for detecting early cardiac rejection in a heart transplant patient by using an ultrasound echocardiogram to measure and compare the ventricular wall mechanics of the patient's transplanted heart to a measured property of the patient's native vasculature.
The rejection of a transplanted heart by a transplant patient's immune system can be a serious complication in heart transplantation. The transplanted heart contains antigens that can stimulate an immune response from the transplant patient's lymphocytes. Despite routine use of immunosuppressive drugs, the rapidity and severity of heart transplant rejection reactions are often variable and unpredictable, and rejection reactions can be life-threatening.
After heart transplantation, patients are generally monitored for rejection by endomyocardial biopsies that are typically obtained from the right ventricle on a periodic basis. Endomyocardial biopsy is invasive and carries significant risk of adverse side effects. In addition, the results are subject to a high degree of variability, and are not effective in identifying rejections within the first few days of transplantation, possibly delaying needed immunosuppressant therapy. Thus, there is a need in the art for a non-invasive and consistent method for detecting early signs of rejection for transplanted hearts.
Sonography is well-known in the art as a non-invasive method of using ultrasound to image and gathering information about organs and other soft tissues. Echocardiography is sonography of the heart and echocardiograms generally use standard ultrasound techniques to image two-dimensional slices of the heart.
There are a number of modes in which ultrasound can be used to produce images of objects. The ultrasound transmitter may be placed on one side of the object and the sound transmitted through the object to the ultrasound receiver placed on the other side (“transmission mode”). With transmission mode methods, an image may be produced in which the brightness of each pixel is a function of the amplitude of the ultrasound that reaches the receiver (“attenuation” mode), or the brightness of each pixel is a function of the time required for the sound to reach the receiver (“time-of-flight” or “speed of sound” mode). In the alternative, the receiver may be positioned on the same side of the object as the transmitter and an image may be produced in which the brightness of each pixel is a function of the amplitude or time-of-flight of the ultrasound reflected from the object back to the receiver (“refraction”, “backscatter” or “echo” mode). The present invention relates to a backscatter method for producing ultrasound images.
There are a number of well known backscatter methods for acquiring ultrasound data. In the so-called “A-mode” scan method, an ultrasound pulse is directed into the object by the transducer and the amplitude of the reflected sound is recorded over a period of time. The amplitude of the echo signal is proportional to the scattering strength of the refractors in the object and the time delay is proportional to the range of the refractors from the transducer. In the so-called “B-mode” scan method, the transducer transmits a series of ultrasonic pulses as it is scanned across the object along a single axis of motion. The resulting echo signals are recorded as with the A-mode scan method and their amplitude is used to modulate the brightness of pixels on a display. The location of the transducer and the time delay of the received echo signals locates the pixels to be illuminated. With the B-mode scan method, enough data are acquired from which a two-dimensional image of the refractors can be reconstructed. Rather than physically moving the transducer over the subject to perform a scan it is more common to employ an array of transducer elements and electronically move an ultrasonic beam over a region in the subject.
In addition, later ultrasound systems allow real-time 3D imaging in echocardiograms. Using pulsed or continuous wave Doppler ultrasound, an echocardiogram can also produce accurate assessments of the velocity of blood and cardiac tissue at any chosen point. Doppler systems employ an ultrasonic beam to measure the velocity of moving reflectors, such as flowing blood cells or the movement of tissue. Blood velocity or tissue velocity is detected by measuring the Doppler shifts in frequency imparted to ultrasound by reflection from moving red blood cells. Accuracy in detecting the Doppler shift at a particular point depends on defining a small sample volume at the required location and then processing the echoes to extract the Doppler-shifted frequencies.
Doppler imaging is often incorporated into real-time imaging systems, which provide electronic steering and focusing of a single acoustic beam and enables small volumes to be illuminated anywhere in the field-of-view (FOV) of the instrument. These locations can be visually identified on a two-dimensional B-mode image. A Fourier transform processor computes the Doppler spectrum backscattered from the sampled volumes, and by averaging the spectral components the mean frequency shift can be obtained. Typically, the calculated velocity is used to color code pixels in the B-mode image.
Despite the large variety of resources available for performing an echocardiogram or otherwise imaging the heart, it is difficult to accurately non-invasively identify the onset of a transplant rejection and it is difficult to discern characteristics of early transplant rejection without performing a biopsy. Therefore, it would be desirable to have a system and method for the early and non-invasive identification of heart transplant rejection and its symptoms.
The present invention overcomes the aforementioned drawbacks by providing a system and method to non-invasively detect early cardiac rejection in heart transplant patients. It has been discovered that changes in the relationship between the native vasculature and ventricle wall mechanics occur in early cardiac rejection. Accordingly, the present invention provides a method for detecting cardiac rejection in a subject having a transplanted heart using a medical imaging apparatus. The method includes measuring a mechanical property of a ventricle wall in the transplanted heart with the medical imaging apparatus, measuring a property of the subjects's native vasculature with the medical imaging apparatus, and comparing the measured mechanical property of the ventricle to the measured property of the native vasculature. The method further includes generating a report indicative of a likelihood of cardiac rejection in the subject by matching a result of the comparison to a priori information acquired from subjects having transplanted hearts that experience cardiac rejection or subjects having transplanted hearts that do not experience cardiac rejection.
The invention is not limited to these aspects, and various other features of the present invention will be made apparent from the following detailed description and the drawings.
The present invention provides a method for identifying cardiac rejection based on measurements describing the motion of a transplanted heart and the motion of native structures within the transplant recipient. These measurements can be performed using a variety of medical imaging modalities, however, they can be performed efficiently and inexpensively using ultrasound. Thus, the following discussion relates primarily to the identification of cardiac rejection via ultrasound imaging.
Referring particularly to
Referring particularly to
As indicated above, to steer the transmitted beam of the ultrasonic energy in the desired manner, the pulses 52 for each of the N channels must be produced and delayed by the proper amount. These delays are provided by a transmit control 54 which receives control signals from the digital controller 16 (
Referring particularly to
The beam forming section 101 of the receiver 14 includes N separate receiver channels 110. Each receiver channel 110 receives the analog echo signal from one of the TGC amplifiers 105 at an input 111, and it produces a stream of digitized output values on an I bus 112 and a Q bus 113. Each of these I and Q values represents a sample of the echo signal envelope at a specific range (R). These samples have been delayed in the manner described above such that when they are summed at summing points 114 and 115 with the I and Q samples from each of the other receiver channels 110, they indicate the magnitude and phase of the echo signal reflected from a point P located at range R on the ultrasonic beam.
Referring still to
M=√{square root over (I2+Q2)}
The detection process 120 may also implement correction methods such as that disclosed in U.S. Pat. No. 4,835,689. Such correction methods examine the received beam samples and calculate corrective values that can be used in subsequent measurements by the transmitter 13 and receiver 14 to improve beam focusing and steering. Such corrections are necessary, for example, to account for the non-homogeneity of the media through which the sound from each transducer element travels during a scan.
The mid processor may also include a Doppler processor 122. Such Doppler processors often employ the phase information (φ) contained in each beam sample to determine the velocity of reflecting objects along the direction of the beam (i.e. direction from the transducer 11), where:
φ=tan−1(I/Q).
The mid processor may also include a correlation flow processor 123, such as that described in U.S. Pat. No. 4,587,973, issued May 13, 1986 and entitled “Ultrasonic Method Can Means For Measuring Blood Flow And The Like Using Autocorrelation”. Such methods measure the motion of reflectors by following the shift in their position between successive ultrasonic pulse measurements.
The Velocity Vector Imaging (VVI) technique (Siemens Medical Solutions) can be used to analyze echocardiogram signals to determine cardiac tissue border movement in real time at any point in the cardiac cycle. VVI tracks motion using an integrated algorithm and can be used to calculate and display (in a color coded three-dimensional visual display known as a parametric map) ventricular wall mechanics, including quantities for wall shear, stress, and strain at any point of the ventricular wall. Recently, it has been demonstrated that VVI can also be used to visualize the wall mechanics of the aorta (see B. B. Kuersten, H. W. Rahmouni, J. C. Main, J. Davidson, M. G. St John Sutton, S. E. Wiegers, Novel Velocity Vector Imaging Ultrasound Technique Demonstrates Asymmetric Deformation in the Normal Aortic Root, Poster: 925-38 ACC 2006: Philadelphia/US).
The arterial-ventricular relationship and its effect on vessel wall mechanics and other vessel characteristics can be evaluated using echocardiogram measurements and VVI analysis of wall motion and deformation in the ventricle and in native vasculature such as the aorta. In healthy subjects, the wall mechanics patterns of the aorta and ventricle clearly show the typical helical pattern of the aorta and the twist and untwist of the ventricle. With aging, the walls of the native vasculature become stiffer and thicker. In transplant patients, the native vasculature age is different from the transplanted heart age. Thus, the relationship between the wall mechanics patterns of the ventricle and certain properties of the native vasculature is somewhat different in heart transplant patients than it is in normal patients. Because the difference between the native vasculature age and the transplanted heart age applies to the native vasculature as a whole rather than being limited to the native aorta, the wall mechanics of the ventricle can be compared to a number of different age-related properties from any part of the native vasculature. Thus, the present invention is not limited to comparisons of the wall mechanics patterns of the ventricle and the aorta.
Referring to
“Wall mechanics” refers to calculated values indicative of the mechanical properties of the tissue, such as wall shear, wall stress, and wall strain at specific locations on the ventricle or vasculature wall tissue as calculated and recorded continually in real time. In “real time” means that calculations are done for each reconstructed image frame. “Wall shear” is the force acting parallel to the surface of the wall tissue caused by the movement of blood or other fluid through a blood vessel or cardiac ventricle and “wall stress” is the pressure exerted per unit cross-sectional tissue wall area for a defined cross-section of the cardiac ventricle or blood vessel. Likewise, “wall strain” is a measure of the deformation of a given tissue wall section relative to its original length so that a tissue wall that is stretched beyond its normal length has a positive wall strain, while a tissue wall that is contracted to a length shorter than its normal length has a negative wall strain.
Referring to
It should be noted that measuring a property of the native vasculature is not limited to imaging the area around the heart. For example, another property of the native vasculature that can be measured by ultrasound is the intima-media thickness (IMT). The intima and the media are the two inner layers of the arterial wall and they generally thicken with age. Thus, an IMT test can determine apparent vascular age and health. Intimal thickening is a complex process that depends on a variety of factors, including changes in shear stress and blood pressure. Because the carotid artery of the neck is more easily accessible by an ultrasound probe, IMT tests are typically performed on the carotid artery (CIMT), rather than the vasculature near the heart. The most common CIMT test uses an FDA-approved software program, SonoCalc, obtains CIMT measurements for many different points along each carotid artery to determine an average thickness. Therefore, it may be advantageous to perform an IMT test on the ceratoid artery of the neck rather than the vasculature near the heart when measuring this property of the native vasculature.
At process block 201, the acquired ultrasound data is analyzed to quantify ventricular wall mechanics. This can be performed using motion tracking or ultrasound analysis software such as AxiUS™ “Velocity Vector Imaging (VVI),” which is made and distributed by Siemens Medical Solutions. VVI uses an angle independent algorithm to evaluate strain and velocities and it performs whole heartbeat analysis using Fourier techniques and constraints on the global coherence of the tracked geometry. VVI first tracks reference points and then scales the motion of adjacent points based on the observed motion of the reference points. At a second order of refinement, VVI tracks the tissue/cavity border using local correlations and snake contouring. At a third order of refinement, image speckles are tracked along the direction of the border. At each level, tracking is initially done over a 2 cm band and then refined over successively smaller bands down to 5 pixels. The VVI software allows the points of interest to be manually set. For example, in analyzing ventricular wall mechanics, one point of interest may be a location in the cardiac left ventricle wall.
The tracking algorithm is automatically applied to a set of points on a contour in a sequence of two dimensional sequences of B-mode images. The velocity is displayed as a vector overlaid on the B-mode image. The length and direction of the tracking arrows reflects the magnitude and direction of the velocity vector at that point. Application of this method to an entire R-R interval provides a “real time” display of cardiac tissue motion. Preferably, VVI is used to convert three-dimension real time images into detailed wall mechanics data, including measurements of stress, strain, and wall shear.
At process block 202, the acquired ultrasound data is analyzed to quantify a property of the native vasculature. For example, aortic wall mechanics can be quantified from the acquired ultrasound data using ultrasound analysis software as discussed above for process block 201. Data corresponding to other properties of the native vasculature, such as wall thickness or cross-sectional area, can also be analyzed and quantified at step 202.
Referring now to
Referring again to
The present invention therefore allows the early identification of post-transplant cardiac rejection by analyzing relationships between a property of a subject's native vasculature and the ventricular wall mechanics of the transplanted heart. These relationship patterns are fundamentally different for patients with normally functioning transplanted hearts versus patients undergoing early cardiac rejection. Specifically, the relationship patterns in patients undergoing early cardiac rejection show an identifiable pattern of disorganization over patients whose transplanted hearts are functioning normally.
The present invention has been described in terms of preferred embodiments, and it should be appreciated that many equivalents, alternatives, variations, and modifications, aside from those expressly stated, are possible and within the scope of the invention. Therefore, the invention should not be limited to a particular described embodiments.
This application is based on, claims the benefit of, and incorporates herein by reference U.S. Provisional Application Ser. No. 61/130,645, filed Jun. 2, 2008, and entitled “Method for Detecting Early Cardiac Transplant Rejection.”
Number | Date | Country | |
---|---|---|---|
61130645 | Jun 2008 | US |